Is Biogen Inc. (BIIB) the Best QQQ Stock to Buy According to Analysts?
Yahoo Finance UK · 2 weeks ago
Open | 177.00 |
High | 179.20 |
Low | 173.66 |
Mkt. Cap | 25.42b |
P/E(TTM) | 15.77 |
Div & Yield | N/A & N/A |
Prev. Close | 176.93 |
52 Wk. Low | 170.71 |
52 Wk. High | 268.30 |
Related stocks
American multinational biotechnology company
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Wikipedia
BIIB (NasdaqGS) $174.45 -2.48 (-1.40%)
Wed, Nov 6, 2024, 3:16PM EST
(USD) | Q3 2024 | Y/Y |
---|---|---|
Revenue | 2.47B | 2.50% ▼ |
Net Income | 388.5M | - |
Diluted EPS | 4.08 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $3.79 | $4.08 |
Q2 2024 | $4.02 | $5.28 |
NIKKEI 225^N225 | 39,480.67+1,005.77 (+2.61%) |
HANG SENG^HSI | 20,538.38-468.59 (-2.23%) |
CRUDE OILCL=F | 71.80-0.19 (-0.26%) |